Phase IIa clinical trial of histone-H1-3 [OncoHist] for the treatment of refractory and relapsed acute myeloid leukaemia and an additional undisclosed orphan cancer indication.
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2014
At a glance
- Drugs Histone H1-3 (Primary)
- Indications Acute myeloid leukaemia; Cancer
- Focus Adverse reactions; Therapeutic Use
- 26 Nov 2014 New trial record